Since the 1980s, HIV-1 non-B subtype infections have been observed in Belgium and they have been mainly associated with sub-Saharan African migrants and heterosexual risk behavior. In the last decade, a rapid spread of subtype F1 was recognized among men having sex with men, previously predominantly characterized by subtype B infections. In this setting of co-circulating subtypes within a local risk group, we want to estimate the frequency of dual infections and the emergence of recombinant strains using next-generation sequencing. At least one plasma sample was selected from each HIV-1 patient who was diagnosed with a subtype F1 (*n* = 41) or BF1 recombinant (*n* = 6) infection. The subtype was defined based upon population-based PR-RT consensus Sanger sequences (Rega v3 subtyping tool). In addition, samples from ten HIV-1 patients whose PR-RT sequence displayed high similarity (\>97.5 per cent) within the B fragment of several BF1 recombinants were included. Near full-length consensus HIV-1 sequences were obtained for eighty-five samples by multiplexing six overlapping amplicons. Samples were fragmented using Illumina's Nextera^®^ XT DNA Library Prep kit and sequenced on a MiSeq sequencing system (2×250 bp). Analysis was performed using the bioinformatics pipeline developed at the Institute of Immunology and Genetics. Consensus sequences were deduced from nucleotide frequencies (15 per cent threshold) and were submitted to the Rega v3 subtyping tool. A concordant subtype classification was obtained for thirty-one patients initially diagnosed with a subtype F1 infection (76 per cent), for nine subtype B (90 per cent) and six BF1 infections (100 per cent). Nine subtype F1 infections were reclassified as BF1 recombinants and two superinfections were identified (F1→BF1 and B→F1). When the threshold for consensus generation was reduced, it resulted into reclassifications for an additional ten patients. This study confirms that the diversity within a HIV-1 epidemic is underestimated when PR-RT Sanger sequencing is used for surveillance studies. However, the next-generation sequencing methodology used was developed for the reconstruction of the consensus sequence that summarizes the viral population within a patient, but could also be subject to inaccuracies due to in vitro and in silico selection biases and recombination events. Alternative strategies are required to perform a more in-depth analysis of dual infections and recombination.
